Oncology Pharmacy Residency

ASHP Program Match Codes

NMS Code 603660 – Roswell Park Track (3 positions)

NMS Code 603690 – Roswell Park - UB Track (1 position)

PGY-2 Oncology Pharmacy Residency training builds upon the foundations of pharmacy practice established during Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency experience.

The purpose of the Roswell Park Comprehensive Cancer Center’s PGY-2 Oncology Pharmacy Residency is to prepare clinical pharmacists for board certification in oncology pharmacy, advanced patient care, academic opportunities, and research to advance our profession.

During your ASHP-accredited, twelve-month, PGY-2 Oncology Pharmacy at Roswell Park, you’ll work with cancer patients across the treatment continuum, from recently diagnosed, through active treatment, and into remission in a variety of different cancer types. Our collaborative, interdisciplinary approach puts you on the front lines with our world-renowned physicians, scientists and technicians.

Eligibility and how to apply

Roswell Park’s PGY-2 training requires a Doctor of Pharmacy (PharmD) degree and completion of a PGY-1 residency program.

For your application package, you’ll need:

Curriculum vitae
A letter of intent
Three letters of recommendation

Interviews will be conducted virtually.

We’re committed to a program of equal opportunity. Selection of residents is made without regard to race, color, national origin, sex, age or sexual orientation.

ASHP PGY-2 Purpose Statement

PGY2 Residency Programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.

Core rotations

The Oncology Pharmacy Residency is a 12-month training program. Core and elective rotations are offered in inpatient and outpatient settings.

A research project of publishable quality is required upon completion of the program.

Specialty Area	Length
Acute Care Services (ID, Critical Care, Palliative, or Hospitalist)	3 weeks
Breast	4 weeks
Gastrointestinal (GI)	4 weeks
Genitourinary (GU)	4 weeks
Gynecology (GYN)	3 weeks
Leukemia (Inpatient)	4 weeks
Lymphoma/Intro to Myeloma (Inpatient/Outpatient)	4 weeks
Multiple Myeloma	3 weeks
Orientation	3 weeks
Thoracic Medicine (THM)	4 weeks
Transplant and Cellular Services (Inpatient/Outpatient)	4 weeks

Longitudinal rotations

Continuity Clinics

Specialty Area	Length
Leukemia Clinic — 4 hours weekly	13 weeks
Oral Chemotherapy Clinic — 4 hours weekly	26 weeks
Transplant and Cellular Therapy Vaccine Clinic— 4 hours weekly	13 weeks

Non-Clinical Areas of Focus

Specialty Area	Length
DUE/QI	45 weeks
Education (Didactic Teaching) — August-April	35 weeks
Medication Order Set Committee (Heme & Solid)	26 weeks
Medication Safety	13 weeks
Oncology Professional Practice — 4 hours biweekly for 26 weeks	52 weeks
Pharmacy Operations	43 weeks
Preceptorship	4 weeks
Professional Development — July-June	50 weeks
Research Project — July-May	48 weeks

Specialty Area	Length
Breast Medicine (Advanced)	2 weeks
Critical Care in Oncology	3 weeks
Gastrointestinal (Advanced)	2 weeks
Gynecology (Advanced)	2 weeks
Head and Neck Cancers	2 weeks
Infectious Disease in Oncology	3 weeks
Inpatient Solid Tumors Service	3 weeks
Leukemia (Inpatient/Advanced)	2 weeks
Leukemia (Outpatient/Advanced)	2 weeks
Lymphoma/Myeloma (Advanced)	2 weeks
Pain and Palliative Care	3 weeks
Pediatrics (Outpatient)	2 weeks
Sarcoma/Melanoma	2 weeks
Thoracic (Advanced)	2 weeks
Transplant and Cellular Services (Outpatient/Advanced)	2 weeks